Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)
China · Delayed Price · Currency is CNY 73.64
+0.19 (0.26%)
At close: Feb 13, 2026
SHE:301617 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 174.86 | 213.13 | 182.1 | 176.32 | 103.29 | 64.04 |
Depreciation & Amortization | 27.5 | 27.5 | 25.11 | 22.27 | 19.71 | 15.97 |
Other Amortization | 1.04 | 1.04 | - | 0.61 | 0.17 | 0.02 |
Loss (Gain) From Sale of Assets | 0.03 | 0.03 | - | -0.34 | - | 0.03 |
Asset Writedown & Restructuring Costs | 0.12 | 0.12 | 4.51 | 7.36 | 3.66 | 7.67 |
Loss (Gain) From Sale of Investments | - | - | -1.4 | 1.85 | 1.4 | -6.26 |
Other Operating Activities | -113.74 | 1.21 | -0.06 | 0.22 | 2.05 | 3.05 |
Change in Accounts Receivable | -51.41 | -51.41 | -83.26 | -64.99 | -42.21 | -52.26 |
Change in Inventory | -39.27 | -39.27 | -34.46 | -36.26 | -27.5 | -1.41 |
Change in Accounts Payable | 8.71 | 8.71 | 55.01 | 80.65 | 19.37 | 16.59 |
Change in Other Net Operating Assets | 0.04 | 0.04 | -1.01 | 0.91 | -0.39 | 1.82 |
Operating Cash Flow | 7.86 | 161.06 | 146.23 | 188.95 | 79.51 | 48.97 |
Operating Cash Flow Growth | -94.66% | 10.14% | -22.61% | 137.64% | 62.36% | - |
Capital Expenditures | -75.17 | -55.45 | -66.98 | -135.05 | -67.93 | -37.89 |
Sale of Property, Plant & Equipment | 0.24 | 0.09 | - | 0.64 | 0.06 | 0.15 |
Divestitures | - | - | - | - | - | 18.88 |
Investment in Securities | -435 | - | 69.15 | -45.63 | -18.52 | 3.4 |
Other Investing Activities | 5.97 | - | 1.4 | 0.61 | 8.23 | -7.11 |
Investing Cash Flow | -503.95 | -55.36 | 3.58 | -179.42 | -78.17 | -22.57 |
Short-Term Debt Issued | - | - | 0.77 | 71.52 | 66.82 | 46.5 |
Total Debt Issued | 0.95 | - | 0.77 | 71.52 | 66.82 | 46.5 |
Short-Term Debt Repaid | - | - | -0.05 | -70.52 | -91.14 | -40.57 |
Long-Term Debt Repaid | - | -0.28 | -1.59 | -1.18 | -0.47 | - |
Total Debt Repaid | -0.28 | -0.28 | -1.64 | -71.69 | -91.61 | -40.57 |
Net Debt Issued (Repaid) | 0.67 | -0.28 | -0.87 | -0.18 | -24.79 | 5.93 |
Issuance of Common Stock | 663.46 | 663.46 | - | - | 50.43 | 0.16 |
Common Dividends Paid | -88.41 | - | - | - | -1.96 | -1.85 |
Other Financing Activities | -53.29 | -36.83 | -2.41 | -0.46 | - | -41.62 |
Financing Cash Flow | 522.43 | 626.34 | -3.28 | -0.64 | 23.68 | -37.38 |
Foreign Exchange Rate Adjustments | -1.55 | -1.18 | 0.11 | 0.35 | -0.02 | 0 |
Net Cash Flow | 24.79 | 730.87 | 146.64 | 9.25 | 25.01 | -10.97 |
Free Cash Flow | -67.31 | 105.61 | 79.26 | 53.9 | 11.58 | 11.08 |
Free Cash Flow Growth | - | 33.26% | 47.04% | 365.44% | 4.51% | - |
Free Cash Flow Margin | -4.83% | 7.95% | 7.73% | 6.75% | 2.21% | 2.92% |
Free Cash Flow Per Share | -0.47 | 1.05 | 0.79 | 0.54 | 0.12 | 0.12 |
Cash Interest Paid | - | - | 0 | 0.46 | - | - |
Cash Income Tax Paid | 52.76 | 66.69 | 57.02 | 52.79 | 28.21 | 21.53 |
Levered Free Cash Flow | -92.16 | 82.49 | 26.9 | 62.01 | 8.89 | -40.78 |
Unlevered Free Cash Flow | -92.16 | 82.51 | 26.9 | 62.3 | 10.12 | -38.88 |
Change in Working Capital | -81.94 | -81.94 | -64.03 | -19.34 | -50.76 | -35.54 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.